P27 BRCA/HRD genetic status does not increase toxicity to PARP inhibitors or next-line cytotoxic chemotherapy in women with epithelial ovarian cancer
Year: 2022
Type: conference-abstract
Source: Gynecologic Oncology
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4281618142
